Purpose: Prexasertib, a checkpoint kinase 1 inhibitor, demonstrated single-agent activity in
patients with advanced squamous cell carcinoma (SCC) in the dose-escalation portion of a …

Bacterial bloodstream infections (BSI) cause significant transplant-related morbidity and
mortality following allogeneic hematopoietic cell transplantation (allo-HCT). This manuscript …

Objective To examine the incidence, treatment, and consequences of febrile neutropenia
across inpatient and outpatient care settings. Methods Data were obtained from Humedica's …

Febrile neutropenia (FN) is an oncological emergency and serious complication often
resulting from chemotherapy. In patients with a weak or completely suppressed immune …

Zusammenfassung Der Einsatz multimodaler Therapiekonzepte für urologische
Tumorerkrankungen konfrontiert den Urologen zunehmend mit den Nebenwirkungen der …

This stud y examined the epidemiology, risk factors, management, and outcome of invasive
fungal infection (IFI) in patients receiving chemotherapy for hematological malignancy in …

Febrile neutropenia (FN) is a common dose-limiting toxicity of chemotherapy, with a
profound impact on the evolution of patients with cancer, due to the potential development of …

Febrile neutropenia (FN) can occur at any time during the course of a malignancy, especially
hematologic malignancies, from diagnosis to end-stage disease. The majority of FN …

To identify research priorities and appropriate resources and to establish the infrastructure
required to address the emergency care of patients with cancer, the National Institutes of …

Purpose: Febrile neutropenia (FN) is an oncologic emergency, and prolonged time to
antibiotic administration (TTA) is associated with increased hospital length of stay (LOS) and …